In 2023, the import volume of pacemakers for stimulating heart muscles stood at 102.50 thousand kilograms. From 2024 onwards, the forecast indicates a progressive decline, with values dropping from 93.77 thousand kilograms in 2024 to 61.04 thousand kilograms by 2028. Observing the year-on-year variations, 2025 shows a reduction of roughly 8.98% from 2024. This decreasing trend continues through to 2028, averaging a compounded annual growth rate (CAGR) of approximately -10.1% over the five-year period. This suggests an overall downtrend in the volume of imports.

Future trends to watch for:

The impact of technological advancements in cardiology that might affect demand for imported pacemakers.
Shifts in domestic production capacities and capabilities within the United States.
Changes in health policies or regulations that could influence the import landscape and preferences.